Participants 154 187 5
patients with cardiac syndrome X.
Participants 543 582 4
patients with cardiac syndrome X (CSX).
Participants 583 699 7
Thirty-six patients with CSX were randomly assigned to 1200 mg/d of Xuezhikang or placebo group (n=18 respectively).
Participants 1705 1723 5
patients with CSX.
